João Amorim is an Analyst at Catalio Capital Management, LP.
He is also a postdoctoral researcher at Harvard Medical School. His research uses techniques in metabolism, epigenetics, and reprogramming to study fundamental questions about how we age and how small molecules can treat aging and aging-related diseases.
He earned an M.S. in Cellular and Molecular Biology and a Ph.D. in Experimental Biology and Biomedicine, both from the University of Coimbra, Portugal.